Drugs Information: Canakinumab
Basic Information
|
||
| ID | DDInter281 | |
| Drug Type | biotech | |
| Molecular Formula | C6452H9958N1722O2010S42 | |
| Molecular Weight | - | |
| Description | Canakinumab is an interleukin-1β blocker used to treat Periodic Fever Syndromes such as Cryopyrin-Associated Periodic Syndromes (CAPS) and Familial Mediterranean Fever (FMF), and also to treat active Systemic Juvenile Idiopathic Arthritis (SJIA). | |
| ATC Classification | L04AC08 | |
| IUPAC Name | None | |
| InChI | None | |
| InChI Key | None | |
| Canonical SMILES | None | |
| Useful Links | DrugBank | |
Interactions with Canakinumab
| Severity level | ID | Name | Mechanism | Detail |
|---|